用Tanshinone I向补充剂C3降低了微质介导的突触吞以产生抗抑郁作用
Huaqing Lai1, Pinglong Fan1, Pengxiang Zhang1
1School of Pharmaceutical Sciences, Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Theranostics
|August 27, 2025
概括
在小鼠中,Tanshinone I (Tan I) 通过向补充物C3 (C3),减少突触损失和改善大脑网络活动来表现出抗抑郁作用. 这种天然化合物通过调节微质活动为抑郁症提供了新的治疗策略.
科学领域:
- 神经科学
- 药理学
- 免疫学
背景情况:
- 目前的抑郁症治疗有局限性, 需要新的治疗策略.
- 一种天然化合物Tanshinone I (Tan I) 具有抗炎,抗氧化和细胞死亡调节的特性.
- 坦I的抗抑郁作用和潜在机制在很大程度上还未被探索.
研究的目的:
- 为了研究Tanshinone I (Tan I) 的抗抑郁作用.
- 阐明Tan I的作用机制,重点关注微质介导的突触过程和大脑网络变化.
- 为了确定Tan I的特定分子目标.
主要方法:
- 动物模型:慢性不可预测压力 (CUS) 的小鼠和C3过度表达的小鼠.
- 评估抗抑郁药效果的行为测试.
- 用于标识的测试 (药物亲和度响应标稳定性,微量热泳).
- 功能磁共振成像 (fMRI) 来评估大脑网络的变化.
- 组织学分析以评估突触损失和微质激活.
主要成果:
- 在CUS小鼠中,Tan I显著改善了类似抑郁的行为,减少了突触损失,并抑制了微质激活.
- I直接与补充C3 (C3) 结合,作为一个C3调节器.
- 坦I抑制了突触上的C3沉积和随后的微质介导突触吞,改善了基于fMRI的网络变化.
- C3过度表达诱导了类似抑郁症的行为,突触损失和网络活动的改变,这些都得到了Tan I治疗的改善.
结论:
- I通过直接调节补充C3 (C3) 来表现出强大的抗抑郁作用.
- 它阻断了C3-CR3轴和STAT3信号,抑制了微质介导的突触修剪.
- 它改善了大脑网络功能,改善了抑郁行为,
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
344
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
344
01:25Antidepressant Drugs: Overview
750
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
750
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
568
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
568
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.2K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.2K